INTERNATIONAL PATENT: GENZYME CORPORATION FILES APPLICATION FOR "TREATMENT OF FACTOR X DEFICIENCY WITH FITUSIRAN"

GENEVA, Oct. 15 -- GENZYME CORPORATION (450 Water StreetCambridge, Massachusetts 02141) filed a patent application (PCT/US2025/022329) for "TREATMENT OF FACTOR X DEFICIENCY WITH FITUSIRAN" on Mar 31, 2025. With publication no. WO/2025/212516, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CASARI, Caterina (c/o INSERM Unite 1176/Paris-Saclay80 rue du General Leclerc94276 Le Kremlin-Bicetre), CHRISTOPHE, Olivier (c/o INSERM Unite 1176/Paris-Saclay80 rue du General Leclerc94276 Le Kremlin-Bicetre), DENIS, Cecile (c/o INSERM...